| VPS35 mutations in Parkinson disease C Vilariño-Güell, C Wider, OA Ross, JC Dachsel, JM Kachergus, ... The American Journal of Human Genetics 89 (1), 162-167, 2011 | 1090 | 2011 |
| Translation initiator EIF4G1 mutations in familial Parkinson disease MC Chartier-Harlin, JC Dachsel, C Vilariño-Güell, SJ Lincoln, F Leprêtre, ... The American Journal of Human Genetics 89 (3), 398-406, 2011 | 408 | 2011 |
| Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice HL Melrose, JC Dächsel, B Behrouz, SJ Lincoln, M Yue, KM Hinkle, ... Neurobiology of disease 40 (3), 503-517, 2010 | 310 | 2010 |
| Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice M Yue, KM Hinkle, P Davies, E Trushina, FC Fiesel, TA Christenson, ... Neurobiology of disease 78, 172-195, 2015 | 267 | 2015 |
| LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors KM Hinkle, M Yue, B Behrouz, JC Dächsel, SJ Lincoln, EE Bowles, ... Molecular neurodegeneration 7, 1-17, 2012 | 220 | 2012 |
| Mice lacking α-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration RE Drolet, B Behrouz, KJ Lookingland, JL Goudreau Neurotoxicology 25 (5), 761-769, 2004 | 172 | 2004 |
| LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease C Vilariño-Güell, C Wider, OA Ross, B Jasinska-Myga, J Kachergus, ... neurogenetics 11, 401-408, 2010 | 168 | 2010 |
| A comparative study of Lrrk2 function in primary neuronal cultures JC Dächsel, B Behrouz, M Yue, JE Beevers, HL Melrose, MJ Farrer Parkinsonism & related disorders 16 (10), 650-655, 2010 | 118 | 2010 |
| LINGO1 rs9652490 is associated with essential tremor and Parkinson disease C Vilariño-Güell, OA Ross, C Wider, B Jasinska-Myga, SA Cobb, ... Parkinsonism & related disorders 16 (2), 109-111, 2010 | 102 | 2010 |
| Neonatal androgen‐dependent sex differences in lumbar spinal cord dopamine concentrations and the number of A11 diencephalospinal dopamine neurons SS Pappas, CT Tiernan, B Behrouz, CL Jordan, SM Breedlove, ... Journal of Comparative Neurology 518 (13), 2423-2436, 2010 | 36 | 2010 |
| Lack of D2 receptor mediated regulation of dopamine synthesis in A11 diencephalospinal neurons in male and female mice SS Pappas, B Behrouz, KL Janis, JL Goudreau, KJ Lookingland Brain research 1214, 1-10, 2008 | 33 | 2008 |
| Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and … M Benskey, B Behrouz, J Sunryd, SS Pappas, SH Baek, M Huebner, ... Neurotoxicology 33 (3), 321-331, 2012 | 32 | 2012 |
| Unique responses to mitochondrial complex I inhibition in tuberoinfundibular dopamine neurons may impart resistance to toxic insult B Behrouz, RE Drolet, ZA Sayed, KJ Lookingland, JL Goudreau Neuroscience 147 (3), 592-598, 2007 | 30 | 2007 |
| Mitochondrial translation initiation factor 3 polymorphism and Parkinson's disease B Behrouz, C Vilariño-Güell, MG Heckman, AI Soto-Ortolaza, JO Aasly, ... Neuroscience letters 486 (3), 228-230, 2010 | 28 | 2010 |
| Substrate‐mediated enhancement of phosphorylated tyrosine hydroxylase in nigrostriatal dopamine neurons: evidence for a role of α‐synuclein RE Drolet, B Behrouz, KJ Lookingland, JL Goudreau Journal of neurochemistry 96 (4), 950-959, 2006 | 25 | 2006 |
| Calbindin‐1 association and Parkinson’s disease AI Soto‐Ortolaza, B Behrouz, C Wider, C Vilariño‐Güell, MG Heckman, ... European journal of neurology 17 (2), 208-211, 2010 | 14 | 2010 |
| Effects of sildenafil on nigrostriatal dopamine neurons in a murine model of Parkinson's disease KL Janis, RT Brennan, RE Drolet, B Behrouz, SK Kaufman, ... Journal of Alzheimer's Disease 15 (1), 97-107, 2008 | 9 | 2008 |
| Comparison of the D2 receptor regulation and neurotoxicant susceptibility of nigrostriatal dopamine neurons in wild-type and CB1/CB2 receptor knockout mice TJ Simkins, KL Janis, AK McClure, B Behrouz, SS Pappas, A Lehner, ... Journal of Neuroimmune Pharmacology 7, 533-538, 2012 | 6 | 2012 |
| Design and high-throughput implementation of MALDI-TOF/MS-based assays for Parkin E3 ligase activity R Traynor, J Moran, M Stevens, O Antico, A Knebel, B Behrouz, ... Cell Reports Methods 4 (2), 2024 | 3 | 2024 |
| Elaboration of a MALDI-TOF mass spectrometry-based assay of parkin activity and high-throughput screening platform for parkin activators R Traynor, J Moran, M Stevens, A Knebel, B Behrouz, K Merchant, ... bioRxiv, 2022.03. 04.482851, 2022 | 2 | 2022 |
